09:45 AM EST - Sirona Biochem Corp. : Will assess its novel skin lightener, TFC-1067, at a concentration three times higher than what was used in the previous clinical trial. Higher dosing is expected to have increased efficacy, but also the potential to work more quickly than the clinically effective dose established for TFC-1067. This positive development is of substantial commercial interest to potential cosmetic partners in North America and China who share Sirona's goal to maximize efficacy without compromising safety. Sirona Biochem Corp.
shares V.SBM are trading down $0.11 at $0.48.
